Home/enVVeno Medical/J. Michael Rosenthal

JM

J. Michael Rosenthal

Chief Financial Officer

enVVeno Medical

Therapeutic Areas

Cardiovascular Vascular Disease

enVVeno Medical Pipeline

Drug	Indication	Phase
VenoValve	Severe Symptomatic Deep Venous Chronic Venous Insufficiency (CVI) due to Proximal Deep Venous Reflux	Pivotal
Next-Generation Venous Valve	Chronic Venous Insufficiency	Pre-Clinical

Leadership Team at enVVeno Medical

Robert B. G. White

President, Chief Executive Officer & Director

James R. Reinstein

Chief Operating Officer

Marc H. Glickman

Senior Vice President & Chief Medical Officer

View full enVVeno Medical profile